Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multidrug-Resistant Tuberculosis”

153 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 153 results

Not applicableStudy completedNCT04928378
What this trial is testing

Bone Resistant Tuberculosis

Who this might be right for
Bone and Osteoarticular Infection Due to MDR M. Tuberculosis Strains
Assistance Publique - Hôpitaux de Paris 23
Large-scale testing (Phase 3)Study completedNCT01061593
What this trial is testing

Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV

Who this might be right for
TuberculosisHIV
Lisichansk Regional Tuberculosis Dispensary 269
Not applicableEnded earlyNCT04783727
What this trial is testing

PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantBacterial Infections+1 more
Research Center Borstel 4
Testing effectiveness (Phase 2)Looking for participantsNCT05534750
What this trial is testing

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

Who this might be right for
TuberculosisMultidrug Resistant Tuberculosis
Assistance Publique - Hôpitaux de Paris 60
Post-approval studies (Phase 4)Study completedNCT01521364
What this trial is testing

Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients

Who this might be right for
Multidrug-resistant TuberculosisExtensively Drug-resistant Tuberculosis
University Medical Center Groningen 7
Large-scale testing (Phase 3)Study completedNCT04207112
What this trial is testing

Economic Evaluation of New MDR TB Regimens

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug-Resistant TuberculosisPulmonary Tuberculoses
Medecins Sans Frontieres, Netherlands 73
Testing effectiveness (Phase 2)Study completedNCT00664313
What this trial is testing

TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
Centers for Disease Control and Prevention 36
Not applicableLooking for participantsNCT05671718
What this trial is testing

Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment

Who this might be right for
Drug Resistant Tuberculosis
Johns Hopkins University 2,944
Testing effectiveness (Phase 2)Study completedNCT02193776
What this trial is testing

To Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.

Who this might be right for
Tuberculosis
Global Alliance for TB Drug Development 240
Not applicableStudy completedNCT03000517
What this trial is testing

PK of Levofloxacin in MDR-TB Patients

Who this might be right for
Multi-drug Resistant Tuberculosis
University Medical Center Groningen 20
Early research (Phase 1)Study completedNCT02236078
What this trial is testing

Brief Bactericidal Activity of Anti-Tuberculosis Drugs

Who this might be right for
TuberculosisDrug-resistant TuberculosisIsoniazid Resistant Tuberculosis (Disorder)
Centers for Disease Control and Prevention 18
Post-approval studies (Phase 4)Study completedNCT05278988
What this trial is testing

Ultrashort PRS Regimen V in the Treatment of MDR-TB

Who this might be right for
MDR-TB
Shanghai Pulmonary Hospital, Shanghai, China 60
Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Not applicableActive Not RecruitingNCT02129244
What this trial is testing

A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes

Who this might be right for
MDR-TBHIV
Johns Hopkins University 3,600
Not applicableLooking for participantsNCT05022238
What this trial is testing

Hotspots, Households and Hospitals: Enhanced Drug-resistant Tuberculosis Case Finding in Namibia

Who this might be right for
Tuberculosis, Multidrug-Resistant
University of Namibia 2,100
Large-scale testing (Phase 3)Looking for participantsNCT05081401
What this trial is testing

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

Who this might be right for
Multidrug Resistant TuberculosisRifampicin Resistant TuberculosisPre-XDR-TB
Huashan Hospital 1,050
Not applicableUnknownNCT04397536
What this trial is testing

New Genomic Techniques and Management of Multidrug-resistant Tuberculosis

Who this might be right for
Multi-Drug Resistant Tuberculosis
Assistance Publique - Hôpitaux de Paris 172
Not applicableStudy completedNCT03303963
What this trial is testing

DIAgnostics for Multidrug Resistant Tuberculosis in Africa

Who this might be right for
Tuberculosis, Multidrug-Resistant
Dissou AFFOLABI 3,356
Testing effectiveness (Phase 2)Study completedNCT00910871
What this trial is testing

To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA 241
Not applicableStudy completedNCT02597621
What this trial is testing

Biomarkers for Therapy Response in Drug-resistant Tuberculosis

Who this might be right for
Tuberculosis, Multidrug-resistant
Research Center Borstel 192
Load More Results